Evaluation of Anterior Middle Brain Structures With Cerebrovascular Flow in Fetuses With Fetal Growth Restriction
1 other identifier
observational
90
1 country
1
Brief Summary
The study will be conducted to examine the effects of abnormal growth pattern and cerebrovascular blood flow measurements on fetal frontal lobe development with the advancing ultrasound technology. Antenatal assessment of frontal lobe development will enable clinicians to predict neurodevelopmental problems that may develop postnatally. In addition, this study will examine the effects of FGR on frontal lobe development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2023
CompletedFirst Submitted
Initial submission to the registry
December 22, 2023
CompletedFirst Posted
Study publicly available on registry
January 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 4, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2024
CompletedJuly 8, 2024
July 1, 2024
1.1 years
December 22, 2023
July 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ultrasonographic measurements and comparison of fetuses with and without fetal growth retardation
Demographic data, ultrasonographically obtained biometric measurements, and Doppler flow data will be compared in both groups. * Frontal Anterior Posterior Length, Occipital to Frontal Diameter ratio mm/mm (FAPD mm/OFD mm) * Cerebellar length, head circumference length ratio mm/mm (CD mm / HC mm) The main biometric measurement of the study will be comparison. The percentile values of the Anterior Cerebral Artery Doppler Pulsatility Index (cm/s) (ACA PI cm/s ) and Middle Cerebral Artery Doppler Pulsatility Index cm/s (MCA PI cm/s) will be calculated for the week of ultrasonographic measurement, and the ratio of ACA PI and MCA PI will be compared in fetuses with and without fetal growth retardation.
Prenatal (32-37 gestational weeks)
Secondary Outcomes (1)
Evaluation of neonatal findings of the patients included in the study
through study completion, an average of 4 months
Study Arms (2)
Pregnant Women with Fetal Growth Restriction
Fetuses with fetal growth restriction according to Delphi consensus criteria between 32-37 weeks of gestation
Healthy Pregnancies
Normally developing fetuses between 32-37 weeks of gestation
Interventions
Evaluation will be performed by ultrasonography. The following measurements will be taken with the ultrasonographic examination. * BPD (Biparietal Diameter) * HC (Head Circumference) * AC (Abdominal Circumference) * FL (Femur Length) * EFW (Estimated Fetal Weight) * Umbilical Artery Doppler Sistole/Diastole (S/D) ,Pulsatility İndex (PI), Resistance İndex (RI) * Middle Cerebral Artery S/D,PI,RI * Uterine Artery Doppler PI * Anterior Cerebral Artery S/D,PI,RI * CPUR (Cerebral - Placental - Uterin PI Ratio) * CPR (Cerebral - Placental PI Ratio) * The deepest free single vertical pocket in the amnion mai * Cavum Septum Pellucidum: Width - Length Diameters * OFD (Occipitofrontal length) * FAPD (Frontal Anterior Posterior Diameter) * FAPD/OFD ratio * Cerebellar diameter * Lateral ventricle depth * Insular depth * Sylvian fissure depth
Eligibility Criteria
The study will include normally developing fetuses between 32-37 weeks of gestation and fetuses with fetal growth restriction.
You may qualify if:
- Healthy hearts between the ages of 18-40
- Singleton pregnancies
- to 37 weeks gestational week range
You may not qualify if:
- Multiple pregnancies
- Fetuses with fetal karyotype abnormalities
- Pregnant women with co-morbidity
- Fetuses with fetal intracranial hemorrhage
- Fetuses with cranial anomalies
- Maternal obesity preventing measurement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Etlik City Hospital
Ankara, Yenimahalle, 06000, Turkey (Türkiye)
Related Publications (1)
Ulusoy CO, Agaoglu RT, Sucu ST, Kurt DS, Bucak M, Seyhanli Z, Yucel KY. Evaluation of Anterior and Middle Brain Structures With Cerebrovascular Flow in Fetuses With Fetal Growth Restriction: A Prospective Study. J Clin Ultrasound. 2025 Feb;53(2):262-270. doi: 10.1002/jcu.23857. Epub 2024 Oct 8.
PMID: 39377442DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 22, 2023
First Posted
January 22, 2024
Study Start
May 15, 2023
Primary Completion
July 4, 2024
Study Completion
July 20, 2024
Last Updated
July 8, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
In accordance with hospital policy, it is not allowed to share data with third parties. If necessary, the chief researcher can be contacted